Report #2839579

Received May 5, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Female
Age: 62 yrs
State: NJ
Recovered: Unknown
Vaccinated: Apr 22, 2025
Onset: Apr 22, 2025
Days to onset: 0
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
VARZOS	ZOSTER (SHINGRIX)	GLAXOSMITHKLINE BIOLOGICALS	UNK	HA5HL	—

Symptoms (1)

Product preparation issue

Symptom narrative

administering the liquid portion only; administering the liquid portion only; This non-serious case was reported by a nurse via call center representative and described the occurrence of inappropriate dose of vaccine administered in a 62-year-old female patient who received Herpes zoster (Shingrix) (batch number HA5HL, expiry date 13-NOV-2026) for prophylaxis. On 22-APR-2025, the patient received Shingrix. On 22-APR-2025, an unknown time after receiving Shingrix, the patient experienced inappropriate dose of vaccine administered (Verbatim: administering the liquid portion only) and inappropriate preparation of medication (Verbatim: administering the liquid portion only). The outcome of the inappropriate dose of vaccine administered and inappropriate preparation of medication were not applicable. Additional Information: GSK receipt date: 29-APR-2025 The nurse called to verify when the dose of Shingrix could be repeated after administering the liquid portion only which led to, inappropriate dose of vaccine administered and inappropriate preparation of medication. The Vaccine Administration Facility is the same as Primary Reporter.